These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10079395)

  • 41. The biochemistry of cyst fluids.
    Miller WR
    Br J Clin Pract Suppl; 1989 Nov; 68():94-9; discussion 111-5. PubMed ID: 2488573
    [No Abstract]   [Full Text] [Related]  

  • 42. Breast cyst fluids increase the proliferation of breast cell lines in correlation with their hormone and growth factor concentration.
    Enriori PJ; Vázquez SM; Chiauzzi V; Pérez C; Fischer CR; Gori JR; Etkin AE; Charreau E; Calandra RS; Lüthy IA
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):20-8. PubMed ID: 16402924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relationship between basic fibroblast growth factor and transforming growth factor-beta 2 in breast cyst fluid.
    Lai LC; Siraj AK; Erbas H; Lennard TW
    J Clin Endocrinol Metab; 1995 Feb; 80(2):711-4. PubMed ID: 7852541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid hormones in fibrocystic breast disease.
    Martínez L; Castilla JA; Gil T; Molina J; Alarcón JL; Marcos C; Herruzo A
    Eur J Endocrinol; 1995 Jun; 132(6):673-6. PubMed ID: 7788004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between levels of dehydroepiandrosterone-sulphate and prolactin in human breast cyst fluid.
    Angeli A; Boccuzzi G; Agrimonti F; Brignardello E; Barbadoro E; Dogliotti L
    Tumori; 1982 Oct; 68(5):393-6. PubMed ID: 6217610
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alpha 1-antichymotrypsin complexes in human breast cyst fluids.
    Mannello F; Malatesta M; Bocchiotti G; Gazzanelli G
    Cancer Lett; 1994 Jan; 76(2-3):155-9. PubMed ID: 8149344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease.
    Boccuzzi G; Brignardello E; Massobrio M; Bonino L
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1099-102. PubMed ID: 2958288
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification.
    Borchert GH; Melegos DN; Yu H; Giai M; Roagna R; Ponzone R; Sgro L; Diamandis EP
    Clin Biochem; 1999 Feb; 32(1):39-44. PubMed ID: 10074890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oestradiol and epidermal growth factor in breast cyst fluid.
    Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
    Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The biochemistry of breast cyst fluids and duct secretions.
    Sartorius OW
    Breast Cancer Res Treat; 1995 Sep; 35(3):255-66. PubMed ID: 7579496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting dehydroepiandrosterone sulphate levels in human breast secretions.
    Miller WR; Humeniuk V; Forrest AP
    Breast Cancer Res Treat; 1981; 1(3):267-72. PubMed ID: 6216932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios.
    Lai LC; Ghatei MA; Takahashi K; Patel KV; Schrey MP; Ghilchik MW; Bloom SR; James VH
    Int J Cancer; 1990 Dec; 46(6):1014-6. PubMed ID: 2249889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast cyst fluid heparan sulphate is distinctively N-sulphated depending on apocrine or flattened type.
    Mannello F; Maccari F; Ligi D; Santi M; Gatto F; Linhardt RJ; Galeotti F; Volpi N
    Cell Biochem Funct; 2015 Apr; 33(3):128-33. PubMed ID: 25753066
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dehydroepiandrosterone induces the transforming growth factor-beta production by murine macrophages.
    Wu MF; Chang HL; Tseng J
    Int J Tissue React; 1997; 19(3-4):141-8. PubMed ID: 9506315
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesterone.
    Boccardo F; Torrisi R; Zanardi S; Valenti G; Pensa F; De Franchis V; Barreca A; Ferraro P; Minuto F
    Int J Cancer; 1991 Feb; 47(4):523-6. PubMed ID: 1995483
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intracystic lipidic profile in fibrocystic breast disease.
    Martínez L; Castilla JA; Gil T; Molina J; Díaz MA; Mozas J; Herruzo A
    Gynecol Endocrinol; 1994 Dec; 8(4):287-92. PubMed ID: 7709769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K(+)-ATPase (NKA) inhibitory activity in human breast cyst fluid.
    Weber CJ; Kim D; Costanzo M; Morris J; Howe B; Ward L; D'Agati V; McDonald T; O'Dorisio TM; Butler VP
    Ann Surg Oncol; 1994 Jul; 1(4):339-44. PubMed ID: 7850533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between the concentrations of estriol sulfate and estrone sulfate in human breast cyst fluid.
    Levitz M; Raju U; Arcuri F; Brind JL; Vogelman JH; Orentreich N; Granata OM; Castagnetta L
    J Clin Endocrinol Metab; 1992 Sep; 75(3):726-9. PubMed ID: 1387652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipids status in human breast cyst fluids.
    Mannello F; Bocchiotti GD; Morano FP; Fratepietro LM; Gazzanelli G
    Cancer Lett; 1996 Jan; 98(2):137-43. PubMed ID: 8556700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mammary cysts: pathophysiology and biochemistry.
    Angeli A; Dogliotti L; Orlandi F; Beccati D
    Int J Rad Appl Instrum B; 1987; 14(4):397-406. PubMed ID: 2958434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.